https://www.selleckchem.com/pr....oducts/Temsirolimus.
08, 95%CI 1.28-3.37, p = 0.003; adjusted OR 2.06, 95%CI 1.03-4.10, p = 0.04), but not in overweight participants. There was no statistically significant evidence for the interaction between hs-CRP and BMI on any cognitive sub-item. Conclusion Elevated hs-CRP levels increase the odds of cognitive impairment in normal-weight participants, but not in overweight participants.Background and Aims Disability-adjusted life years (DALYs) are an important measure of the global burden of disease that informs patient outcomes and policy decisi
Beğen
Yorum Yap
Paylaş
